Bella Thornton-Clark

CV

Since 2024 Senior Associate, Taylor Wessing

2022 - 2024 Associate, Taylor Wessing

2020 - 2022 Associate, Gunderson Dettmer, San Francisco

Carrière

Since 2024 Senior Associate, Taylor Wessing

2022 - 2024 Associate, Taylor Wessing

2020 - 2022 Associate, Gunderson Dettmer, San Francisco

Formation

2019 Admission to California Bar

2019 J.D. University of Texas School of Law

Experience

Blue Earth Therapeutics on the closing of US$76.5 million Series A funding

We have advised Blue Earth Therapeutics and its management on the closing of US$76.5 million Series A funding. The new funding comes from a broad spectrum of experienced biotech investors and enables Blue Earth Therapeutics to further advance its clinical stage prostate-specific membrane antigen-targeted radioligand therapies.

Press release

Ross McNaughton

Bella Thornton-Clark

Advising gene therapy company AlveoGene on its complex spinout and launch investment

We have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.

Press release

Ross McNaughton

Bella Thornton-Clark

Actualités et publications récentes

View Bella 's insights

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Lingotto on its extended Series A funding into Optalysys to US$60 million

6 février 2026

par plusieurs auteurs

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising EpilepsyGTx on its US$33 million Series A financing

10 décembre 2025

par plusieurs auteurs

Cliquer ici pour en savoir plus

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising on £40 million growth investment into Osprey Flight Solutions

9 septembre 2025

par plusieurs auteurs

Cliquer ici pour en savoir plus

Bella Thornton-Clark

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Experience

Blue Earth Therapeutics on the closing of US$76.5 million Series A funding

Advising gene therapy company AlveoGene on its complex spinout and launch investment

Actualités et publications récentes

Advising Lingotto on its extended Series A funding into Optalysys to US$60 million

Bella Thornton-Clark

Expertise

Services et Groupes

Secteurs

CV

Carrière

Formation

Experience

Blue Earth Therapeutics on the closing of US$76.5 million Series A funding

Advising gene therapy company AlveoGene on its complex spinout and launch investment

Actualités et publications récentes

Advising Lingotto on its extended Series A funding into Optalysys to US$60 million

Related news & insights

Taylor Wessing’s China Group wins three awards at the 2026 China Business Law Awards

MiCA 2.0: The EU Commission launches consultation on the next chapter of EU crypto regulation

Taylor Wessing advises the insolvency administrator on the sale of Sympatex Technologies GmbH to Pidigi

The AI Boom Meets Regulation: Mandatory EU Labeling for Data Centers

Advising Corten Capital on its investment in Beacon Intelligence

Taylor Wessing is advising Hypax on the acquisition of the Powerbox Group in a complex carve-out transaction from Cosel

Taylor Wessing advises EIC Fund and NRW.BANK on EUR 57 million Series A financing round of eleQtron

Taylor Wessing advises greentech on the sale of a 27 MWp photovoltaic portfolio to STRABAG

#8: Online Payment Fraud Prevention: PSD3 & PSR, AI and beyond

Taylor Wessing advises the shareholders of anemos Gesellschaft für Umweltmeteorologie GmbH on the sale of the entire company to Vidia GmbH

Autres avocats qui pourraient vous intéresser

Rendez-vous à